Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues
- PMID: 1979007
- DOI: 10.1002/mrd.1080270203
Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues
Abstract
The human uterus repeatedly exhibits cyclic biochemical and cytological changes during the reproductive period of life. These changes are the result of a well-characterized endocrine network involving the hypothalamus, pituitary, and ovary. The exact nature of the mechanism(s) by which the sex steroids act on the uterus remains to be elucidated. Possible local mediators of hormonal action on the uterus include polypeptide growth factors. Using the method of RNA transfer blot hybridization, we have analyzed tissue samples from the cycling human endometrium and tissue samples of human myometrium and myometrial benign tumor (leiomyoma) for the presence of platelet-derived growth factor (PDGF) and insulin-like growth factor (IGF) RNA. All the uterine tissues examined possessed RNA for PDGF-B chain and IGF-I and -II. Two transcripts were observed for PDGF-B chain, four were observed for IGF-I, and eight were observed for IGF-II. Overall, the relative abundance of PDGF-B chain RNA was consistent in all of the uterine tissues examined. In contrast, IGF RNA relative abundance varied. IGF-I RNA was highest in late proliferative stage endometrium, and IGF-II RNA was highest in early proliferative stage endometrium. Both IGF-I and IGF-II RNAs were greater in amount of leiomyoma than in myometrium. The increased IGF-I RNA in late proliferative-stage human endometrium correlates with the known elevation of estradiol secretion by the ovary and the increased concentration of uterine estradiol receptors during this stage of the menstrual cycle.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry.Cancer Res. 1992 Jun 15;52(12):3453-9. Cancer Res. 1992. PMID: 1317752
-
Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.Cancer Res. 1991 Sep 15;51(18):4978-85. Cancer Res. 1991. PMID: 1893385
-
Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.J Oral Pathol Med. 2007 Apr;36(4):198-206. doi: 10.1111/j.1600-0714.2007.00516.x. J Oral Pathol Med. 2007. PMID: 17391297
-
Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals.Placenta. 2000 May;21(4):289-305. doi: 10.1053/plac.1999.0498. Placenta. 2000. PMID: 10833363 Review.
-
Expression of IGF ligand and receptor genes during preimplantation mammalian development.Mol Reprod Dev. 1993 Aug;35(4):414-20. doi: 10.1002/mrd.1080350416. Mol Reprod Dev. 1993. PMID: 8398121 Review.
Cited by
-
Genetic determinants of uterine fibroid size in the multiethnic NIEHS uterine fibroid study.Int J Mol Epidemiol Genet. 2015 Sep 9;6(1):9-19. eCollection 2015. Int J Mol Epidemiol Genet. 2015. PMID: 26417400 Free PMC article.
-
Dietary glycemic index and load in relation to risk of uterine leiomyomata in the Black Women's Health Study.Am J Clin Nutr. 2010 May;91(5):1281-8. doi: 10.3945/ajcn.2009.28698. Epub 2010 Mar 3. Am J Clin Nutr. 2010. PMID: 20200259 Free PMC article.
-
Epidemiology of Uterine Fibroids: From Menarche to Menopause.Clin Obstet Gynecol. 2016 Mar;59(1):2-24. doi: 10.1097/GRF.0000000000000164. Clin Obstet Gynecol. 2016. PMID: 26744813 Free PMC article. Review.
-
Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.Mol Med. 2008 May-Jun;14(5-6):264-75. doi: 10.2119/2007-00101.Yu. Mol Med. 2008. PMID: 18231572 Free PMC article.
-
Antiestrogen action and growth factor regulation.Breast Cancer Res Treat. 1994;31(1):61-71. doi: 10.1007/BF00689677. Breast Cancer Res Treat. 1994. PMID: 7981458 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources